References
- BlackSWYamanakaAKilduffTSChallenges in the development of therapeutics for narcolepsyProg Neurobiol Epub2015122325784645
- BassettiCAldrichMSNarcolepsyNeurol Clin19961435455718871976
- BoganRSwickTMamelakMEvaluation of quality of life in patients with narcolepsy treated with sodium oxybate: use of the 36-item short-form health survey in a clinical trialNeurol Ther20165220321327778193
- SwickTJTreatment paradigms for cataplexy in narcolepsy: past, present, and futureNat Sci Sleep2015715916926715865
- NishinoSSakuraiENevsimalovaSDecreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controlsSleep200932217518019238804
- LongstrethWTJrKoepsellTDTonTGHendricksonAFvan BelleGThe epidemiology of narcolepsySleep2007301132617310860
- MaskiKUnderstanding racial differences in narcolepsy symptoms may improve diagnosisSleep201538111663166426446120
- AhmedSSMontomoliEPasiniFLSteinmanLThe safety of adjuvanted vaccines revisited: vaccine-induced narcolepsyIsr Med Assoc J2016183–421622027228647
- KamalRMvan NoordenMSFranzekEDijkstraBALoonenAJDe JongCAThe neurobiological mechanisms of gamma-hydroxybutyrate dependence and withdrawal and their clinical relevance: a reviewNeuropsychobiology2016732658027003176
- ThorpyMJDauvilliersYClinical and practical considerations in the pharmacologic management of narcolepsySleep Med201516191825458251
- SundvikMPanulaPInteractions of the orexin/hypocretin neurons and the histaminergic systemActa Physiol (Oxf)2015213232133325484194
- HaasHLSergeevaOASelbachOHistamine in the nervous systemPhysiol Rev20088831183124118626069
- De la Herran-AritaAKGarcia-GarciaFCurrent and emerging options for the drug treatment of narcolepsyDrugs201373161771178124122734
- ParmentierRAnacletCGuhennecCThe brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disordersBiochem Pharmacol20077381157117117288995
- SchwartzJCLecomteJMClinical trials with H3-receptor inverse agonists: what they tell us about the role of histamine in the human brainNeuropharmacology2016106353627060410
- SyedYYPitolisant: first global approvalDrugs201676131313131827438291
- European Medicines AgencyWakix (Pitolisant): Summary of Product Charatcteristics2017 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002616/WC500204746.pdfAccessed January 4, 2017
- BialerMJohannessenSILevyRHPeruccaETomsonTWhiteHSProgress report on new antiepileptic drugs: a summary of the Twelfth Eilat Conference (EILAT XII)Epilepsy Res20151118514125769377
- LinJSDauvilliersYArnulfIAn inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin−/− mice and patientsNeurobiol Dis2008301748318295497
- DauvilliersYBassettiCLammersGJPitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trialLancet Neurol201312111068107524107292
- SzakacsZDauvilliersYMikhaylovVSafety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trialLancet Neurol201716320020728129985
- InocenteCArnulfIBastujiHPitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepinessClin Neuropharmacol2012352556022356925
- MitlerMMGujavartyKSBrowmanCPMaintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolenceElectroencephalogr Clin Neurophysiol19825366586616177511
- van der HeideAvan SchieMKLammersGJComparing treatment effect measurements in narcolepsy: the sustained attention to response task, Epworth Sleepiness Scale and maintenance of wakefulness testSleep20153871051105825902810
- TanejaASahariaPChadhaNRajputAGoelAA network meta-analysis on comparative efficacy and safety of investigational and approved therapies for the treatment of narcolepsyValue Health2016193A60
- DauvilliersYArnulfISzakacsZLong term use of pitolisant to treat narcolepsy: HARMONY III studyJ Sleep Res201625275
- HidalgoHMayerGGeislerPYoungPKallweitUPitolisant as therapeutic option for narcolepsy: results from the German compassionate-program 2015/16J Sleep Res201625366
- GemkowMJDavenportAJHarichSEllenbroekBACesuraAHallettDThe histamine H3 receptor as a therapeutic drug target for CNS disordersDrug Discov Today2009149–1050951519429511